CIBC Bancorp USA’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Buy
19,048
+482
+3% +$28.4K ﹤0.01% 1082
2026
Q2
$1.04M Buy
18,566
+779
+4% +$40.5K ﹤0.01% 1096
2026
Q1
$853K Buy
+17,787
New +$779K ﹤0.01% 1076
2025
Q3
$480K Buy
+13,598
New +$492K ﹤0.01% 889

Other funds holding RPRX

CIBC Bancorp USA's RPRX Position: Q3 2026 in Review

CIBC Bancorp USA increased its Royalty Pharma (RPRX) stake by 2.6% in Q3 2026, buying an estimated $28.4K and bringing the position to 19,048 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

CIBC Bancorp USA first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. 704 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • CIBC Bancorp USA held 19,048 shares of Royalty Pharma worth $1.11M as of Q3 2026.
  • CIBC Bancorp USA bought 482 Royalty Pharma shares in Q3 2026, an estimated $28.4K.
  • Royalty Pharma made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1082 holding.
  • CIBC Bancorp USA first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • 704 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.